107k views
4 votes
A nurse is assessing a client who has schizophrenia and is taking haloperidol. The nurse should report which of the following to the provider as a manifestation of neuroleptic malignant syndrome (NMS)?

a. Increased appetite.
b. Bradycardia.
c. Hyperthermia.
d. Excessive salivation.

User Silvina
by
7.2k points

1 Answer

5 votes

Final answer:

The nurse should report hyperthermia to the provider as it is a manifestation of neuroleptic malignant syndrome (NMS), a serious side effect of antipsychotic medications like haloperidol.

Step-by-step explanation:

The nurse should report hyperthermia to the provider as a manifestation of neuroleptic malignant syndrome (NMS) when assessing a client with schizophrenia taking haloperidol. NMS is a serious side effect associated with antipsychotic medications, such as haloperidol, and can be life-threatening.

Symptoms of NMS include severe muscle rigidity, fever (hyperthermia), altered mental status, and autonomic dysfunction. Hyperthermia stands out as a key indicator of NMS compared to the other options provided: increased appetite, bradycardia, and excessive salivation.

User Ryansin
by
7.9k points